Area of research
Statistics and Probability · Artificial Intelligence
Research interest
Research focused on Randomized controlled trial and Clinical trial, with related work in Odds, Coronavirus disease 2019 (COVID-19), Covariate. Notable publications include 'Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19', 'Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma', and 'Prospective individual patient data meta‐analysis: Evaluating convalescent plasma for COVID‐19'.
Addiction Consultation Services for Opioid Use Disorder Treatment Initiation and Engagement
AWAreness during REsuscitation - II: A multi-center study of consciousness and awareness in cardiac arrest
Exercise intolerance associated with impaired oxygen extraction in patients with long COVID
Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19
Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma
Prospective individual patient data meta‐analysis: Evaluating convalescent plasma for COVID‐19
Statistical analysis plan for stage 1 EMBARC (Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care) study
Generated effect modifiers (GEM’s) in randomized clinical trials
Treatment Decisions Based on Scalar and Functional Baseline Covariates